Literature DB >> 27699707

Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk.

Adam Hulman1,2,3, Rebecca K Simmons4,5,6, Dorte Vistisen7, Adam G Tabák8,9, Jacqueline M Dekker10,11, Marjan Alssema10,12, Femke Rutters10,11, Anitra D M Koopman10,11, Thomas P J Solomon13,14, John P Kirwan15, Torben Hansen16, Anna Jonsson16, Anette Prior Gjesing16, Hans Eiberg17, Arne Astrup18, Oluf Pedersen16, Thorkild I A Sørensen16,19, Daniel R Witte20,4, Kristine Færch7.   

Abstract

We aimed to examine heterogeneity in glucose response curves during an oral glucose tolerance test with multiple measurements and to compare cardiometabolic risk profiles between identified glucose response curve groups. We analyzed data from 1,267 individuals without diabetes from five studies in Denmark, the Netherlands and the USA. Each study included between 5 and 11 measurements at different time points during a 2-h oral glucose tolerance test, resulting in 9,602 plasma glucose measurements. Latent class trajectories with a cubic specification for time were fitted to identify different patterns of plasma glucose change during the oral glucose tolerance test. Cardiometabolic risk factor profiles were compared between the identified groups. Using latent class trajectory analysis, five glucose response curves were identified. Despite similar fasting and 2-h values, glucose peaks and peak times varied greatly between groups, ranging from 7-12 mmol/L, and 35-70 min. The group with the lowest and earliest plasma glucose peak had the lowest estimated cardiovascular risk, while the group with the most delayed plasma glucose peak and the highest 2-h value had the highest estimated risk. One group, with normal fasting and 2-h values, exhibited an unusual profile, with the highest glucose peak and the highest proportion of smokers and men. The heterogeneity in glucose response curves and the distinct cardiometabolic risk profiles may reflect different underlying physiologies. Our results warrant more detailed studies to identify the source of the heterogeneity across the different phenotypes and whether these differences play a role in the development of type 2 diabetes and cardiovascular disease.

Entities:  

Keywords:  Cardiometabolic risk; Glucose response curve; Latent class trajectory analysis; Oral glucose tolerance test

Mesh:

Substances:

Year:  2016        PMID: 27699707     DOI: 10.1007/s12020-016-1126-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

1.  A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.

Authors:  Torben Jørgensen; Knut Borch-Johnsen; Troels F Thomsen; Hans Ibsen; Charlotte Glümer; Charlotta Pisinger
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2003-10

2.  The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes.

Authors:  Muhammad A Abdul-Ghani; Valeriya Lyssenko; Tiinamaija Tuomi; Ralph A Defronzo; Leif Groop
Journal:  Diabetes Metab Res Rev       Date:  2010-05       Impact factor: 4.876

3.  Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals.

Authors:  M Kanauchi; K Kimura; K Kanauchi; Y Saito
Journal:  Int J Clin Pract       Date:  2005-04       Impact factor: 2.503

4.  Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts.

Authors:  Akram Alyass; Peter Almgren; Mikael Akerlund; Jonathan Dushoff; Bo Isomaa; Peter Nilsson; Tiinamaija Tuomi; Valeriya Lyssenko; Leif Groop; David Meyre
Journal:  Diabetologia       Date:  2014-10-08       Impact factor: 10.122

Review 5.  Roles of the Gut in Glucose Homeostasis.

Authors:  Jens Juul Holst; Fiona Gribble; Michael Horowitz; Chris K Rayner
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

6.  Association between cardiorespiratory fitness and the determinants of glycemic control across the entire glucose tolerance continuum.

Authors:  Thomas P J Solomon; Steven K Malin; Kristian Karstoft; Sine H Knudsen; Jacob M Haus; Matthew J Laye; John P Kirwan
Journal:  Diabetes Care       Date:  2015-03-17       Impact factor: 19.112

7.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

9.  Enzyme immunoassay for intact human insulin in serum or plasma.

Authors:  L Andersen; B Dinesen; P N Jørgensen; F Poulsen; M E Røder
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

10.  HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis.

Authors:  Soraya Soulimane; Dominique Simon; William H Herman; Celine Lange; Crystal M Y Lee; Stephen Colagiuri; Jonathan E Shaw; Paul Z Zimmet; Dianna Magliano; Sandra R G Ferreira; Yanghu Dong; Lei Zhang; Torben Jorgensen; Jaakko Tuomilehto; Viswanathan Mohan; Dirk L Christensen; Lydia Kaduka; Jacqueline M Dekker; Giel Nijpels; Coen D A Stehouwer; Olivier Lantieri; Wilfred Y Fujimoto; Donna L Leonetti; Marguerite J McNeely; Knut Borch-Johnsen; Edward J Boyko; Dorte Vistisen; Beverley Balkau
Journal:  Diabetologia       Date:  2013-09-25       Impact factor: 10.122

View more
  11 in total

Review 1.  Different physiological mechanisms underlie an adverse cardiovascular disease risk profile in men and women.

Authors:  Alan Fappi; Bettina Mittendorfer
Journal:  Proc Nutr Soc       Date:  2019-07-25       Impact factor: 6.297

2.  Time to glucose peak during an oral glucose tolerance test identifies prediabetes risk.

Authors:  Stephanie T Chung; Joon Ha; Anthony U Onuzuruike; Kannan Kasturi; Mirella Galvan-De La Cruz; Brianna A Bingham; Rafeal L Baker; Jean N Utumatwishima; Lilian S Mabundo; Madia Ricks; Arthur S Sherman; Anne E Sumner
Journal:  Clin Endocrinol (Oxf)       Date:  2017-08-06       Impact factor: 3.478

3.  Glucose patterns during the OGTT and risk of future diabetes in an urban Indian population: The CARRS study.

Authors:  Adam Hulman; Unjali P Gujral; K M Venkat Narayan; Rajendra Pradeepa; Deepa Mohan; Ranjit Mohan Anjana; Viswanathan Mohan; Kristine Færch; Daniel R Witte
Journal:  Diabetes Res Clin Pract       Date:  2017-02-17       Impact factor: 5.602

4.  Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate.

Authors:  Adam Hulman; Dorte Vistisen; Charlotte Glümer; Michael Bergman; Daniel R Witte; Kristine Færch
Journal:  Diabetologia       Date:  2017-10-06       Impact factor: 10.122

Review 5.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

6.  The Effect of Prior Gestational Diabetes on the Shape of the Glucose Response Curve during an Oral Glucose Tolerance Test 3 Years after Delivery.

Authors:  Timea Tänczer; Márk M Svébis; Beatrix Domján; Viktor J Horváth; Adam G Tabák
Journal:  J Diabetes Res       Date:  2020-03-04       Impact factor: 4.011

7.  An Acute, Placebo-Controlled, Single-Blind, Crossover, Dose-Response, Exploratory Study to Assess the Effects of New Zealand Pine Bark Extract (Enzogenol®) on Glycaemic Responses in Healthy Participants.

Authors:  Wen Xin Janice Lim; Lynne Chepulis; Pamela von Hurst; Cheryl S Gammon; Rachel A Page
Journal:  Nutrients       Date:  2020-02-15       Impact factor: 5.717

8.  The oral glucose tolerance test-derived incremental glucose peak is associated with greater arterial stiffness and maladaptive arterial remodeling: The Maastricht Study.

Authors:  Yuri D Foreman; Martijn C G J Brouwers; Tos T J M Berendschot; Martien C J M van Dongen; Simone J P M Eussen; Marleen M J van Greevenbroek; Ronald M A Henry; Alfons J H M Houben; Carla J H van der Kallen; Abraham A Kroon; Koen D Reesink; Miranda T Schram; Nicolaas C Schaper; Coen D A Stehouwer
Journal:  Cardiovasc Diabetol       Date:  2019-11-14       Impact factor: 9.951

9.  Post-load glucose subgroups and associated metabolic traits in individuals with type 2 diabetes: An IMI-DIRECT study.

Authors:  Morgan Obura; Joline W J Beulens; Roderick Slieker; Anitra D M Koopman; Trynke Hoekstra; Giel Nijpels; Petra Elders; Robert W Koivula; Azra Kurbasic; Markku Laakso; Tue H Hansen; Martin Ridderstråle; Torben Hansen; Imre Pavo; Ian Forgie; Bernd Jablonka; Hartmut Ruetten; Andrea Mari; Mark I McCarthy; Mark Walker; Alison Heggie; Timothy J McDonald; Mandy H Perry; Federico De Masi; Søren Brunak; Anubha Mahajan; Giuseppe N Giordano; Tarja Kokkola; Emmanouil Dermitzakis; Ana Viñuela; Oluf Pedersen; Jochen M Schwenk; Jurek Adamski; Harriet J A Teare; Ewan R Pearson; Paul W Franks; Leen M 't Hart; Femke Rutters
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

Review 10.  The Oral Glucose Tolerance Test: 100 Years Later.

Authors:  Ram Jagannathan; João Sérgio Neves; Brenda Dorcely; Stephanie T Chung; Kosuke Tamura; Mary Rhee; Michael Bergman
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-19       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.